Latest News & Products
Las Vegas, NV — January 2, 2025 — BioWound Solutions, a Las Vegas, Nevada based leader in innovative wound management solutions, announced it has entered into an exclusive supply agreement with Keraplast Limited, (Keraplast), a global biotechnology company based in Christchurch, New Zealand, that pioneered the use of keratin-based biomaterials for medical applications.
BioWound Solutions, the sole and exclusive owner of the keratin-containing advanced wound care products Keramatrix®, Keragel®, and Keroxx®, has partnered with Keraplast as the manufacturing supplier for these innovative products. Through the manufacturing collaboration, BioWound Solutions will provide clinicians and healthcare providers with access to cutting-edge keratin-based therapies designed to accelerate healing and improve patient outcomes.
“This partnership marks an important milestone for BioWound Solutions,” said Nick Andolino, CEO, BioWound Solutions. “Keraplast’s unique and proprietary keratin technology is transforming wound healing, and we are proud to be the exclusive wound care company bringing these FDA cleared 510(k) solutions to the market. Through our keratin-based therapies, in partnership with Keraplast, we aim to redefine standards of care for patients suffering from chronic wounds.”
Keraplast’s proprietary keratin technology, Replicine™ is backed by decades of scientific research and clinical evidence, demonstrating its ability to promote cellular regeneration, reduce scarring, and support natural wound closure. This agreement ensures BioWound Solutions’ growing network of clients will have streamlined and exclusive access to these important therapies.
“We are excited to collaborate with BioWound Solutions, whose expertise and market presence in the United States, make them the ideal partner for expanding access to our ethically sourced, scientifically proven and functional keratin-based products,” said Howard Moore, CEO, Keraplast. “This agreement strengthens our shared commitment to improving patient care that benefits patients’ lives and delivers meaningful innovation in wound healing.”
The agreement aligns with BioWound Solutions’ mission of vertical integration to deliver high-quality wound management products to healthcare providers and their patients.
About BioWound Solutions
BioWound Solutions is a leading healthcare solutions company that believes that wound care is not just a clinical specialty — it's a mission. Founded on the principles of innovation, integrity, and meaningful collaboration, the company is transforming the way advanced wound care is delivered to patients across the healthcare spectrum.
About Keraplast Limited
Keraplast Limited is a global biotechnology company specializing in the development and commercialization of keratin-based biomaterials for medical, surgical, and dermatological applications. Its patented keratin technology is supported by extensive research and clinical validation.
Media Contact:
Nazim Wahab
Sr. Director of Portfolio Management
BioWound Solutions
725-324-5061
nazim.wahab@biowound.com